Patient info Open main menu

Venlafaxine 150 mg prolonged-release capsules, hard – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
150 mg
Contains active substance:

Patient leaflet - Venlafaxine 150 mg prolonged release capsules, hard

1. What venlafaxine capsules is and what it is used for

Venlafaxine is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is thought that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain.

Venlafaxine capsules is a treatment for adults with depression. Venlafaxine capsules is also a treatment for adults with the following anxiety disorders: generalised anxiety disorder, social anxiety disorder (fear or avoidance of social situations) and panic disorder (panic attacks). Treating depression or anxiety disorders properly is important to help you get better. If it is not treated, your condition may not go away and may become more serious and more difficult to treat.

2. What you need to know before you take venlafaxine capsules

Do not take venlafaxine capsules

  • if you are allergic to venlafaxine or any of the other ingredients of this medicine (listed in section 6)
  • if you are also taking or have taken any time within the last 14 days any medicines known as irreversible monoamine oxidase inhibitors (MAOIs), used to treat depression or Parkinson’s disease. Taking an irreversible MAOI together with other medicines, including venlafaxine capsules, can cause serious or even life-threatening side effects. Also, you must wait at least 7 days after you stop taking venlafaxine capsules before you take any MAOI (see also the section “Taking other medicines”).

Take special care with venlafaxine capsules

  • if you use other medicines that taken concomitantly with venlafaxine could increase the risk of developing serotonin syndrome (see the section “Taking other medicines”)
  • if you have eye problems, such as certain kinds of glaucoma (increased pressure in the eye)
  • if you have a history of high blood pressure
  • if you have a history of heart problems
  • if you have a history of fits (seizures)
  • if you have a history of low sodium levels in your blood (hyponatraemia)
  • if you have a tendency to develop bruises or a tendency to bleed easily (history of bleeding disorders), or if you are pregnant (see ‘Pregnancy and breast-feeding’) or if you are taking other medicines that may increase the risk of bleeding
  • if your cholesterol levels get higher
  • if you have a history of, or if someone in your family has had, mania or bipolar disorder (feeling over-excited or euphoric)
  • if you have a history of aggressive behaviour.

Venlafaxine may cause a sensation of restlessness or an inability to sit or stand still. You should tell your doctor if this happens to you.

If any of these conditions apply to you, please talk with your doctor before taking venlafaxine capsules.

Medicines like venlafaxine capsules (so called SSRIs/SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have continued after stopping treatment.

Thoughts of suicide and worsening of your depression or anxiety disorder

If you are depressed and/or have anxiety disorders, you can sometimes have thoughts of harming or killing yourself. These may be increased when you first start taking antidepressants, since these medicines all take time to work, usually about two weeks, but sometimes longer.

You may be more likely to think like this:

  • If you have previously had thoughts about killing yourself or harming yourself.
  • If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behaviour in young adults (less than 25 years old) with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Dry mouth

Dry mouth is reported in 10% of patients treated with venlafaxine. This may increase the risk of caries. Therefore, you should take special care in your dental hygiene.

Children and adolescents

Venlafaxine capsules should normally not be used for children and adolescents under 18 years. Also, you should know that patients under 18 have an increased risk of side effects, such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. Despite this, your doctor may prescribe venlafaxine capsules for patients under 18 because he/she decides that this is in their best interests. If your doctor has prescribed venlafaxine capsules for a patient under 18, and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking venlafaxine capsules. Also, the long-term safety effects concerning growth, maturation and cognitive and behavioural development of venlafaxine capsules in this age group has not yet been demonstrated.

Other medicines and venlafaxine capsules

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Your doctor should decide whether you can take venlafaxine capsules with other medicines.

Do not start or stop taking any medicines, including those bought without a prescription, natural and herbal remedies, before checking with your doctor or pharmacist.

  • Monoamine oxidase inhibitors which are used to treat depression or Parkinson’s disease must not be taken with venlafaxine. Tell your doctor if you have taken these medicines within the last 14 days. (MAOIs: see the section “Before you take venlafaxine”).

Serotonin syndrome: A potentially life-threatening condition or Neuroleptic Malignant Syndrome (NMS)-like reactions (see the section “Possible Side Effects”), may occur with venlafaxine treatment, particularly when taken with other medicines. Examples of these medicines include:

  • Triptans (used for migraine)
  • Medicines to treat depression, for instance SNRI, SSRIs, tricyclics, or medicines containing lithium
  • Medicines containing linezolid, an antibiotic (used to treat infections)
  • Medicines containing moclobemide, a reversible MAOI (used to treat depression)
  • Medicines containing sibutramine (used for weight loss)
  • Medicines containing tramadol (a pain-killer)
  • Products containing St. John’s wort (also called Hypericum perforatum, a natural or herbal remedy used to treat mild depression)
  • Products containing tryptophan (used for problems such as sleep and depression).
  • Antipsychotics (used to treat a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, unclear reasoning and becoming withdrawn)

Signs and symptoms of serotonin syndrome may include a combination of the following:

restlessness, hallucinations, loss of coordination, fast heartbeat, increased body temperature, fast changes in blood pressure, overactive reflexes, diarrhoea, coma, nausea, vomiting. Get medical care right away if you think serotonin syndrome is happening to you.

The following medicines may also interact with venlafaxine capsules and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medicines containing:

  • Ketoconazole (an antifungal medicine)
  • Haloperidol or risperidone (to treat psychiatric conditions)
  • Metoprolol (a beta blocker to treat high blood pressure and heart problems).

Venlafaxine capsules with food and drink

Venlafaxine capsules should be taken with food (see section 3).

You should avoid alcohol while you are taking venlafaxine capsules.

Pregnancy and breast-feeding

Tell your doctor if you become pregnant, or you are trying to become pregnant. You should use venlafaxine capsules only after discussing the potential benefits and the potential risks to your unborn child with your doctor.

Make sure your midwife and/or doctor knows you are on venlafaxine capsules. When taken during pregnancy, similar drugs (SSRIs) may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately.

If you take venlafaxine capsules near the end of your pregnancy there may be an increased risk of heavy vaginal bleeding shortly after birth, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking venlafaxine capsules so they can advise you.

If you are taking this medicine during pregnancy, other symptoms your baby might have when it is born is not feeding properly, in addition to having trouble breathing. If your baby has these symptoms when it is born and you are concerned, contact your doctor and/or midwife who will be able to advise you.

Venlafaxine passes into breast milk. There is a risk of an effect on the baby.

Therefore, you should discuss the matter with your doctor, and he/she will decide whether you should stop breast-feeding or stop the therapy with venlafaxine capsules.

Driving and using machines

Do not drive or use any tools or machines until you know how venlafaxine capsules affects you.

3. How to take venlafaxine capsules

Always take venlafaxine capsules exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The usual recommended starting dose for treatment of depression, generalised anxiety disorder and social anxiety disorder is 75 mg per day. The dose can be raised by your doctor gradually, and if needed, even up to a maximum dose of 375 mg daily for depression. If you are being treated for panic disorder, your doctor will start with a lower dose (37.5 mg) and then increase the dose gradually. The maximum dose for generalised anxiety disorder, social anxiety disorder and panic disorder is 225 mg/day.

Take Venlafaxine capsules at approximately the same time each day, either in the morning or in the evening. Capsules must be swallowed whole with fluid and not opened, crushed, chewed or dissolved.

Venlafaxine capsules should be taken with food.

If you have liver or kidney problems, talk to your doctor, since your dose of venlafaxine capsules may need to be different.

Do not stop taking venlafaxine capsules without talking to your doctor (see the section “If you stop taking Venlafaxine capsules”).

If you take more venlafaxine capsules than you should

Call your doctor or pharmacist immediately if you take more than the amount of venlafaxine capsules prescribed by your doctor.

The symptoms of a possible overdose may include a rapid heartbeat, changes in level of alertness (ranging from sleepiness to coma), blurred vision, seizures or fits, and vomiting.

If you forget to take venlafaxine capsules

If you miss a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. Do not take more than the daily amount of venlafaxine capsules that has been prescribed for you in one day.

If you stop taking venlafaxine capsules

Do not stop taking your treatment or reduce the dose without the advice of your doctor even if you feel better. If your doctor thinks that you no longer need venlafaxine capsules, he/she may ask you to reduce your dose slowly before stopping treatment altogether. Side effects are known to occur when people stop using venlafaxine capsules, especially when venlafaxine capsules is stopped suddenly or the dose is reduced too quickly.

Some patients may experience symptoms such as tiredness, dizziness, light-headedness, headache, sleeplessness, nightmares, dry mouth, loss of appetite, nausea, diarrhoea, nervousness, agitation, confusion, ringing in the ears, tingling or rarely electric shock sensations, weakness, sweating, seizures, or flu-like symptoms.

Your doctor will advise you on how you should gradually discontinue venlafaxine capsules treatment. If you experience any of these or other symptoms that are troublesome, ask your doctor for further advice.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Allergic reactions

If any of the following happen, do not take more venlafaxine capsules. Tell your doctor immediately, or go to the casualty department at your nearest hospital:

  • Chest tightness, wheezing, trouble swallowing or breathing
  • Swelling of the face, throat, hands, or feet
  • Feeling nervous or anxious, dizziness, throbbing sensations, sudden reddening of the skin and/or a warm feeling
  • Severe rash, itching, or hives (elevated patches of red or pale skin that often itch).
  • Signs and symptoms of serotonin syndrome which may include restlessness, hallucinations, loss of coordination, fast heartbeat, increased body temperature, fast changes in blood pressure, overactive reflexes, diarrhoea, coma, nausea, vomiting.

    In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). Signs and symptoms of NMS may include a combination of fever, fast heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).

Other side effects that you should tell your doctor about include:

  • Coughing, wheezing, shortness of breath and a high temperature
  • Black (tarry) stools or blood in stools
  • Yellow skin or eyes, itchiness or dark urine, which may be symptoms of inflammation of the liver (hepatitis)
  • Heart problems, such as fast or irregular heart rate, increased blood pressure
  • Eye problems, such as blurred vision, dilated pupils
  • Nerve problems, such as dizziness, pins and needles, movement disorder, seizures or fits
  • Psychiatric problems, such as hyperactivity and euphoria (feeling unusually overexcited).
  • Withdrawal effects (see the section “HOW TO TAKE venlafaxine capsules, if you stop taking venlafaxine capsules).

Do not be concerned if you see small white granules or balls in your stools after taking venlafaxine capsules. Inside venlafaxine capsules are spheroids or small white balls that contain the venlafaxine active ingredient. These spheroids are released from the capsule into your gastrointestinal tract. As the spheroids travel the length of your gastrointestinal tract, venlafaxine is slowly released.

The spheroid “shell” remains undissolved and is eliminated in your stools. Therefore, even though you may see spheroids in your stools, your dose of venlafaxine has been absorbed.

Other reported side effects

Very common (affects more than 1 in 10 users)

  • Headache; dry mouth; sweating (including night sweats)
  • Nausea

Common (affects 1 to 10 users in 100)

  • Weight loss; appetite decreased; constipation; vomiting; increased cholesterol
  • Feeling separated (or detached) from yourself and reality; nervousness; confusion; abnormal dreams; insomnia
  • Tremor; increased muscle tonus
  • Pins and needles
  • Increase in blood pressure; flushing, palpitations
  • Increased frequency in urination; difficulties passing urine
  • Decreased libido; abnormal ejaculation/orgasm (males); lack of orgasm; erectile dysfunction (impotence)
  • Menstrual irregularities such as increased bleeding or increased irregular bleeding
  • Weakness (asthenia); dizziness; sedation, chills
  • Blurred vision
  • Yawning

Uncommon (affects 1 to 10 users in 1,000)

  • Bruising; black tarry stools (faeces) or blood in stools, which can be a sign of internal bleeding
  • Grinding of the teeth; involuntary movement of the muscles
  • Hallucinations
  • General swelling of the skin especially the face, mouth, tongue, throat area or hands and feet and/or a raised itchy rash (hives) may be present
  • Sensitivity to sunlight; abnormal hair loss; rash
  • Impaired coordination and balance; feeling dizzy (particularly when standing up too quickly), fainting, fast heartbeat
  • Weight gain; diarrhoea
  • Altered taste sensation
  • Lack of feeling or emotion; agitation
  • Ringing in the ears (tinnitus)
  • Inability to pass urine;
  • Abnormal orgasm (females)

Rare (affects 1 to 10 users in 10,000)

A sensation of restlessness or an inability to sit or stand still; seizures or fits; feeling over-excited or euphoric.

  • Inability to control urination

Frequency not known

  • Reduced number of platelets in your blood, leading to an increased risk of bruising or bleeding; blood disorders which may lead to an increased risk of infection; slight changes in blood levels of liver enzymes; decrease in blood sodium levels;
  • Itchiness, yellow skin or eyes, dark urine, or flu-like symptoms, which are symptoms of inflammation of the liver (hepatitis)
  • Excessive water intake (known as SIADH)
  • Abnormal breast milk production
  • A high temperature with rigid muscles, confusion or agitation, and sweating, or if you experience jerky muscle movements which you can't control, these may be symptoms of serious conditions known as neuroleptic malignant syndrome
  • Euphoric feelings, drowsiness, sustained rapid eye movement, clumsiness, restlessness, feeling of being drunk, sweating or rigid muscles, which are symptoms of serotonergic syndrome
  • Disorientation and confusion often accompanied by hallucination (delirium)
  • Stiffness, spasms and involuntary movements of the muscles
  • Thoughts of harming or killing yourself
  • Severe eye pain and decreased or blurred vision
  • Decrease in blood pressure; abnormal, rapid or irregular heartbeat, which could lead to fainting
  • Coughing, wheezing, shortness of breath and a high temperature, which are symptoms of inflammation of the lungs associated with an increase in white blood cells (pulmonary eosinophilia)
  • Severe abdominal or back pains (which could indicate a serious problem in the gut, liver or pancreas)
  • Skin rash, which may lead to severe blistering and peeling of the skin; itching; mild rash
  • Unexplained muscle pain, tenderness or weakness (rhabdomyolysis)
  • Swollen face or tongue, shortness of breath or difficulty breathing, often with skin rashes (this may be a serious allergic reaction)
  • Confusion
  • Vertigo
  • Aggression
  • Heavy vaginal bleeding shortly after birth (postpartum haemorrhage), see ‘Pregnancy and breast-feeding’ in section 2 for more information

Venlafaxine capsules sometimes causes unwanted effects that you may not be aware of, such as increases in blood pressure or abnormal heartbeat; slight changes in blood levels or liver enzymes, sodium or cholesterol. More rarely, Venlafaxine capsules may reduce the function of platelets in your blood, leading to an increased risk of bruising or bleeding. Therefore, your doctor may wish to do blood tests occasionally, particularly if you have been taking Venlafaxine capsules for a long time.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Venlafaxine capsules

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of that month.

Do not store above 25°C.

Store in the original package in order to protect from moisture.

If your doctor decides to stop treatment, return any leftover capsules to your pharmacist. Only keep them if your doctor tells you to.

REMEMBER this medicine is only for you. Only a doctor can prescribe it for you. Never give it to others. It may harm them even if their signs of illness are the same as yours.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What venlafaxine capsules contains

The active substance is Venlafaxine.

Venlafaxine 37.5mg capsules contain 42.45 mg of venlafaxine hydrochloride equivalent to 37.5mg venlafaxine.

Venlafaxine 75mg capsules contain 84.90 mg of venlafaxine hydrochloride, equivalent to 75mg venlafaxine.

Venlafaxine 150mg capsules contain 169.80 mg of venlafaxine hydrochloride, equivalent to 150mg venlafaxine.

The other ingredients are:

Core:

Microcrystalline cellulose (Avicel PH 102)

Povidone (Plasdone K-90 D)

Hydroxypropyl methylcellulose

Talc

Silica, Colloidal Anhydrous

Magnesium stearate

Film Coating:

Ethyl Cellulose (Ethocel 7 CP STD Premium FP)

Copovidone (Plasdone S-630)

Capsule:

37.5 mg

Black Iron Oxide (E172)

Red Iron Oxide (E172)

Yellow Iron Oxide (E172)

Titanium Dioxide (E171)

Gelatin

Shellac

Propylene Glycol

Strong Ammonia Solution

75 mg

Black Iron Oxide (E172)

Red Iron Oxide(E172)

Titanium Dioxide (E171)

Gelatin

Shellac

Propylene Glycol

Strong Ammonia Solution

150 mg

Brilliant Blue FCF (E133)

Allura Red AC (E129)

Sunset Yellow FCF (E110)

Titanium Dioxide (E171)

Gelatin

Shellac

Povidone

Propylene Glycol

Sodium Hydroxide

What venlafaxine capsules looks like and contents of the pack

Prolonged-release capsule, hard

Venlafaxine capsules 37.5mg: light grey opaque / peach opaque, size “3” hard gelatin capsules having thick and thin radial circular band on the body in red ink and thick and thin radial circular band on the cap in red ink. The capsule is filled with 3 white to off-white, round biconvex, film-coated mini tablets of 12.5mg each.

Venlafaxine capsules 75mg: peach opaque / peach opaque, size “1” hard gelatin capsules having thick and thin radial circular band on the body in red ink and thick and thin radial circular band on the cap in red ink. The capsule is filled with 6 white to off-white, round biconvex, film-coated mini tablets of 12.5mg each.

Venlafaxine capsules 150mg: dark orange / dark orange opaque, size “0” hard gelatin capsules having thick and thin radial circular band on the body in white ink and thick and thin radial circular band on the cap in white ink. The capsule is filled with 12 white to off-white, round biconvex, film-coated mini tablets of 12.5mg each.

Blister pack of PVC/ACLAR film or PVC/PVdC film and Aluminium lidding foil.

Pack-sizes

37.5mg: 7, 10, 14, 20, 28, 30, 50, 90, 100, 500 capsules

75mg: 10, 14, 20, 28, 30, 50, 56, 60, 90, 100, 500 capsules

150mg: 14, 20, 28, 30, 50, 60, 90, 100, 250, 500 capsules

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Quattro Pharma Limited

172 Willows Lane

Bolton, Lancashire

BL3 4BU

United Kingdom

Manufacturer

Strides Pharma UK Limited

The Metro Centre Dwight Road,

Watford WD18 9SS

United Kingdom

This leaflet was last revised in 07/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 52338/0021

Last revision stated in the text: July 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Venlafaxine 150 mg prolonged release capsules, hard

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Venlafaxine
Strength 150 mg
Pharmaceutical form Modified-release capsule
Dark orange / dark orange opaque, size “0” hard gelatin capsules having thick and thin radial circular band on the body in white ink and thick and thin radial circular band on the cap in white ink. The capsule is filled with 12 white to off-white, round biconvex, film-coated mini tablets of 12.5 mg each.
How is it taken Oral
Excipients Microcrystalline cellulose (Avicel PH 102), Povidone (Plasdone K-90 D), Talc, Silica, Colloidal Anhydrous, Magnesium stearate, Ethyl Cellulose (Ethocel 7 CP STD Premium FP), Copovidone (Plasdone S-630), Brilliant Blue FCF (E133), Allura Red AC (E129), Sunset Yellow FCF (E110), Titanium Dioxide (E171), Gelatin, Shellac, Povidone, Propylene Glycol, Sodium Hydroxide
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Do not store above 25°C.
Store in the original package in order to protect from moisture.
Drug group (ATC) Other antidepressants
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AX Other antidepressants
          1. N06AX16 venlafaxine
Marketing authorisation PL 52338/0021 (first authorised 3 July 2023)
Marketing authorisation holder Quattro Pharma Limited
Codes BNF 04030400

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.